Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study

BACKGROUND: More than 1 million prostate biopsies are conducted yearly in the United States. The low specificity of prostate-specific antigen (PSA) results in diagnostic biopsies in men without prostate cancer (PCa). Additional information, such as genetic markers, could be used to avoid unnecessary...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur Urol
Main Authors: Aly, Markus, Wiklund, Fredrik, Xu, Jianfeng, Isaacs, William B., Eklund, Martin, D’Amato, Mauro, Adolfsson, Jan, Grönberg, Henrik
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417350/
https://ncbi.nlm.nih.gov/pubmed/21295399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2011.01.017
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki